Key result
Robotic-assisted resection of cardiac papillary fibroelastoma yields 0 major complications and rapid postoperative discharge.
Why the study?
Surgical excision of symptomatic cardiac papillary fibroelastomas carries significant embolization risk and is conventionally performed via median sternotomy.
Does minimally invasive robotic-assisted resection safely treat cardiac papillary fibroelastoma?
Case Report (n=12)
No
Does minimally invasive robotic-assisted resection safely treat cardiac papillary fibroelastoma?
Robotic-assisted resection of cardiac papillary fibroelastoma is a safe and feasible minimally invasive alternative to median sternotomy.
May support feasibility in small series; hypothesis-generating and requires larger studies before practice change.
Papillary fibroelastomas (PFEs) are small, slowly growing benign cardiac tumors with clinically significant risk of embolization. Surgical excision is the definitive treatment of symptomatic PFE and is conventionally performed through a median sternotomy. In this study, we report a series of 12 patients, who underwent robotic-assisted PFE removal at the Mayo Clinic. PFE involved the mitral valve, left atrium, and tricuspid valve. No major complications occurred after the procedure, and most patients were discharged 4 days after the surgery. On follow-up, 1 patient demonstrated pericarditis.
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2024) conducted a case report in Cardiac Papillary Fibroelastoma (n=12). Robotic-assisted resection was evaluated on Major complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: